Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 20 May 2025
Adolescent and young adult cancer survivors exhibit persistently elevated levels of depression and anxiety throughout their lifespan, but only symptoms of anxiety tend to stabilize in their later years, say University of ...
Read Full NewsSwiss generic drugmaker Sandoz filed a draft anti-dumping complaint with the European Commission over Chinese imports of the antibiotic ingredient amoxicillin.
Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.
Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.
An observational study suggests that bone mineral density may serve as a marker of systemic health.
Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.
Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.
1.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
2.
'Converging' Evidence of Link Between Air Pollution and Breast Cancer
3.
Is Laughter Good for Blood Glucose Control?
4.
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis
5.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
1.
Cracking Oncology Drug Resistance: New Strategies to Overcome Challenges in Modern Cancer Therapy
2.
The Cutting-Edge of Phlebectomy: Redefining Vein Care
3.
Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer
4.
The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy
5.
Transfusing the Future: Exploring the Possibilities of Blood Transfusions
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge